Altre lingue ANGLE plc

Azioni

Mercato chiuso - London S.E. Altri mercati azionari 17:35:21 31/05/2024			Variaz. 5gg	Var. 1 gen.
18,75 ^GBX	+1,35%		-2,60%	+59,57%

16/05	Bens Creek prende in considerazione l'amministrazione; Nexxen conclude un accordo	AN
16/05	ANGLE plc annuncia la pubblicazione di uno studio che utilizza il sistema Parsortix	CI

Bens Creek considers administration; Nexxen inks deal	16/05
ANGLE plc Announces Publication of Study Using the Parsortix System	16/05
Angle shares up on assay development deal with AstraZeneca	03/05
Angle shares up on assay development deal with AstraZenaca	03/05
Angle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to AstraZeneca	03/05
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	03/05
InterContinental Hotels makes first-quarter progress	03/05
ANGLE plc Announces New Commercial Agreement with Large Pharma	03/05
No record close for FTSE 100; mixed trade in US	24/04
No record close for FTSE 100; mixed trade in US	24/04
Angle plc to Develop New Cancer Assay in Deal with AstraZeneca	24/04
Angle shares jump on supplier agreement with with AstraZeneca	24/04
AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook	24/04
Angle PLC Announces New Commercial Agreement with AstraZeneca PLC	24/04
Angle granted patents in US and Europe for Cellkeep slide	22/04
ANGLE plc Presents Parsortix HER2 Assay at AACR Annual Meeting 2024	08/04
Transcript : ANGLE plc - Special Call	06/02
Angle highlights supportive data for DNA analysis tool	22/01
Stocks up ahead of US nonfarm payrolls	04/01
Angle shares soar following "breakthrough" cancer diagnostics results	04/01

Non ci sono risultati per questa ricerca